EP 1248855 A2 20021016 - SEQUENCES CHARACTERISTIC OF BLADDER CANCER
Title (en)
SEQUENCES CHARACTERISTIC OF BLADDER CANCER
Title (de)
CHARAKTERISTISCHE SEQUENZEN FÜR BLASENKREBS
Title (fr)
SEQUENCES CARACTERISTIQUES DU CANCER DE LA VESSIE
Publication
Application
Priority
- US 0041005 W 20000927
- US 15615399 P 19990927
Abstract (en)
[origin: WO0122864A2] There is provided a method of diagnosing the presence of bladder cancer in a patient by analyzing a tissue sample from the patient for the presence of at least one expressed gene wherein the presence of the expressed gene is indicative of bladder cancer. Also provided by the present invention is a polynucleotide sequence whose expression is indicative of bladder cancer. A marker for bladder cancer is also provided. There are also provided methods of diagnosing bladder cancer by screening for the presence of at least one expressed gene wherein the presence of the expressed gene is indicative of bladder cancer. Methods of treating and regulating bladder cancer-associated pathologies by administering to a patient a therapeutically effective amount of a ribozyme, antisense olignucleotide, or agonist against the nucleic acids sequences of the present invention are alos provided.
IPC 1-7
C12Q 1/68; C12N 15/63; C07H 21/02; C07H 21/04; C12P 21/08; C07K 16/00; A61K 31/70; A61K 38/00; A61K 39/395
IPC 8 full level
C12P 21/08 (2006.01); C12Q 1/68 (2006.01); C12Q 1/6886 (2018.01)
CPC (source: EP)
C12Q 1/6886 (2013.01); C12Q 2600/158 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0122864 A2 20010405; WO 0122864 A3 20011101; WO 0122864 A9 20021212; AU 1492601 A 20010430; CA 2385893 A1 20010405; EP 1248855 A2 20021016; EP 1248855 A4 20041222; IL 148798 A0 20020912
DOCDB simple family (application)
US 0041005 W 20000927; AU 1492601 A 20000927; CA 2385893 A 20000927; EP 00977267 A 20000927; IL 14879800 A 20000927